Project Details
Description
A Phase III, double-blind, randomized controlled, multi-center study to evaluate the efficacy of GlaxoSmithKline Biologicals' HPV 580299/008
| Status | Finished |
|---|---|
| Effective start/end date | 9/7/04 → 12/31/09 |
Funding
- GLAXOSMITHKLINE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.